UBS Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $133M | Sell |
545,548
-125,800
| -19% | -$29.3M | 0.02% | 841 |
|
|
2025
Q4 | $139M | Sell |
671,348
-104,296
| -13% | -$20.6M | 0.02% | 782 |
|
|
2025
Q3 | $144M | Buy |
775,644
+104,900
| +16% | +$18M | 0.02% | 775 |
|
|
2025
Q2 | $102M | Sell |
670,744
-149,300
| -18% | -$22.9M | 0.02% | 940 |
|
|
2025
Q1 | $136M | Sell |
820,044
-29,900
| -4% | -$4.68M | 0.03% | 722 |
|
|
2024
Q4 | $123M | Sell |
849,944
-205,200
| -19% | -$31.8M | 0.02% | 789 |
|
|
2024
Q3 | $171M | Buy |
1,055,144
+528,415
| +100% | +$84.2M | 0.04% | 476 |
|
|
2024
Q2 | $77M | Sell |
526,729
-198,415
| -27% | -$29.5M | 0.02% | 775 |
|
|
2024
Q1 | $115M | Sell |
725,144
-246,837
| -25% | -$39.3M | 0.03% | 585 |
|
|
2023
Q4 | $152M | Buy |
971,981
+443,581
| +84% | +$68M | 0.05% | 403 |
|
|
2023
Q3 | $82.3M | Buy |
528,400
+78,200
| +17% | +$12.9M | 0.03% | 580 |
|
|
2023
Q2 | $74.5M | Buy |
450,200
+23,900
| +6% | +$3.86M | 0.03% | 624 |
|
|
2023
Q1 | $66.1M | Sell |
426,300
-353,200
| -45% | -$57M | 0.02% | 645 |
|
|
2022
Q4 | $138M | Buy |
779,500
+112,300
| +17% | +$19.4M | 0.05% | 375 |
|
|
2022
Q3 | $109M | Buy |
667,200
+233,100
| +54% | +$39.4M | 0.05% | 404 |
|
|
2022
Q2 | $77.1M | Sell |
434,100
-119,100
| -22% | -$21.2M | 0.03% | 534 |
|
|
2022
Q1 | $98M | Sell |
553,200
-32,100
| -5% | -$5.46M | 0.03% | 528 |
|
|
2021
Q4 | $100M | Buy |
585,300
+102,876
| +21% | +$16.8M | 0.03% | 600 |
|
|
2021
Q3 | $77.9M | Sell |
482,424
-99,500
| -17% | -$17M | 0.02% | 636 |
|
|
2021
Q2 | $95.9M | Buy |
581,924
+18,500
| +3% | +$3.06M | 0.03% | 536 |
|
|
2021
Q1 | $92.6M | Buy |
563,424
+524
| +0.1% | +$84.8K | 0.03% | 550 |
|
|
2020
Q4 | $88.6M | Buy |
562,900
+86,500
| +18% | +$12.8M | 0.03% | 524 |
|
|
2020
Q3 | $70.9M | Buy |
476,400
+21,600
| +5% | +$3.2M | 0.03% | 508 |
|
|
2020
Q2 | $64M | Sell |
454,800
-80,900
| -15% | -$11.8M | 0.03% | 508 |
|
|
2020
Q1 | $70.2M | Buy |
535,700
+259,600
| +94% | +$36.8M | 0.03% | 442 |
|
|
2019
Q4 | $40.3M | Buy |
276,100
+43,800
| +19% | +$5.94M | 0.01% | 896 |
|
|
2019
Q3 | $30.1M | Buy |
232,300
+69,400
| +43% | +$9.14M | 0.01% | 972 |
|
|
2019
Q2 | $22.7M | Sell |
162,900
-374,500
| -70% | -$51.8M | 0.01% | 1137 |
|
|
2019
Q1 | $75.1M | Sell |
537,400
-210,500
| -28% | -$28.2M | 0.03% | 468 |
|
|
2018
Q4 | $96.5M | Buy |
747,900
+368,000
| +97% | +$51.3M | 0.04% | 376 |
|
|
2018
Q3 | $52.5M | Buy |
379,900
+291,400
| +329% | +$38.7M | 0.02% | 648 |
|
|
2018
Q2 | $10.7M | Sell |
88,500
-110,200
| -55% | -$13.7M | ﹤0.01% | 1685 |
|
|
2018
Q1 | $25.5M | Buy |
198,700
+32,000
| +19% | +$4.33M | 0.01% | 999 |
|
|
2017
Q4 | $23.3M | Sell |
166,700
-10,600
| -6% | -$1.48M | 0.01% | 1092 |
|
|
2017
Q3 | $23.1M | Buy |
177,300
+62,500
| +54% | +$8.29M | 0.01% | 1023 |
|
|
2017
Q2 | $15.2M | Buy |
114,800
+82,400
| +254% | +$10.5M | 0.01% | 1230 |
|
|
2017
Q1 | $4.04M | Sell |
32,400
-240,813
| -88% | -$28.8M | ﹤0.01% | 2273 |
|
|
2016
Q4 | $31.5M | Sell |
273,213
-88,700
| -25% | -$10.2M | 0.02% | 756 |
|
|
2016
Q3 | $42.8M | Buy |
361,913
+11,513
| +3% | +$1.4M | 0.03% | 590 |
|
|
2016
Q2 | $42.5M | Sell |
350,400
-1,260,814
| -78% | -$143M | 0.03% | 559 |
|
|
2016
Q1 | $174M | Buy |
1,611,214
+974,380
| +153% | +$101M | 0.12% | 190 |
|
|
2015
Q4 | $65.4M | Buy |
636,834
+372,055
| +141% | +$37.4M | 0.04% | 419 |
|
|
2015
Q3 | $24.7M | Sell |
264,779
-208,871
| -44% | -$20.2M | 0.02% | 770 |
|
|
2015
Q2 | $46.2M | Buy |
473,650
+259,800
| +121% | +$26M | 0.03% | 554 |
|
|
2015
Q1 | $21.5M | Sell |
213,850
-147,963
| -41% | -$15M | 0.01% | 907 |
|
|
2014
Q4 | $37.8M | Buy |
+361,813
| New | +$38.1M | 0.03% | 658 |
|
Other funds holding JNJ
VCM
VPM
UBS Group's JNJ Position: Q1 2026 in Review
UBS Group increased its Johnson & Johnson (JNJ) stake by 2.3% in Q1 2026, buying an estimated $52.4M and bringing the position to 10,209,327 shares worth $2.5B. The position accounts for 0.37% of the portfolio, ranked #33.
UBS Group first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- UBS Group held 10,209,327 shares of Johnson & Johnson worth $2.5B as of Q1 2026.
- UBS Group bought 225,036 Johnson & Johnson shares in Q1 2026, an estimated $52.4M.
- Johnson & Johnson made up 0.37% of UBS Group's portfolio in Q1 2026, its #33 holding.
- UBS Group first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.